JP2010520745A5 - - Google Patents

Download PDF

Info

Publication number
JP2010520745A5
JP2010520745A5 JP2009548801A JP2009548801A JP2010520745A5 JP 2010520745 A5 JP2010520745 A5 JP 2010520745A5 JP 2009548801 A JP2009548801 A JP 2009548801A JP 2009548801 A JP2009548801 A JP 2009548801A JP 2010520745 A5 JP2010520745 A5 JP 2010520745A5
Authority
JP
Japan
Prior art keywords
prostate cancer
susceptibility
allele
marker
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2009548801A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010520745A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IS2008/000003 external-priority patent/WO2008096375A2/en
Publication of JP2010520745A publication Critical patent/JP2010520745A/ja
Publication of JP2010520745A5 publication Critical patent/JP2010520745A5/ja
Ceased legal-status Critical Current

Links

JP2009548801A 2007-02-07 2008-02-07 前立腺癌のリスクに寄与する遺伝子変異体 Ceased JP2010520745A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IS8604 2007-02-07
IS8654 2007-06-22
PCT/IS2008/000003 WO2008096375A2 (en) 2007-02-07 2008-02-07 Genetic variants contributing to risk of prostate cancer

Publications (2)

Publication Number Publication Date
JP2010520745A JP2010520745A (ja) 2010-06-17
JP2010520745A5 true JP2010520745A5 (enExample) 2011-03-31

Family

ID=39650503

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009548801A Ceased JP2010520745A (ja) 2007-02-07 2008-02-07 前立腺癌のリスクに寄与する遺伝子変異体

Country Status (13)

Country Link
US (1) US8865400B2 (enExample)
EP (2) EP2115171B1 (enExample)
JP (1) JP2010520745A (enExample)
CN (1) CN102317470A (enExample)
AU (1) AU2008212117B2 (enExample)
BR (1) BRPI0807236A2 (enExample)
CA (1) CA2677994A1 (enExample)
IL (1) IL200197A (enExample)
IN (1) IN2009DN05722A (enExample)
MX (1) MX2009008461A (enExample)
NZ (1) NZ579401A (enExample)
SG (1) SG193026A1 (enExample)
WO (1) WO2008096375A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697360B2 (en) 2007-11-30 2014-04-15 Decode Genetics Ehf. Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
US20090226912A1 (en) * 2007-12-21 2009-09-10 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
WO2011149534A2 (en) 2010-05-25 2011-12-01 The Regents Of The University Of California Bambam: parallel comparative analysis of high-throughput sequencing data
US9646134B2 (en) * 2010-05-25 2017-05-09 The Regents Of The University Of California Bambam: parallel comparative analysis of high-throughput sequencing data
WO2012029080A1 (en) * 2010-08-30 2012-03-08 Decode Genetics Ehf Sequence variants associated with prostate specific antigen levels
US9732389B2 (en) 2010-09-03 2017-08-15 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
US9534256B2 (en) 2011-01-06 2017-01-03 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
CN103797120B (zh) * 2011-09-16 2017-04-12 上海长海医院 前列腺癌的生物学标志物、治疗靶点及其用途
CN103060433B (zh) * 2012-10-19 2014-12-03 卫生部北京医院 一种预测前列腺癌易感性的试剂盒和方法
CA2891394C (en) 2012-11-20 2023-03-14 Phadia Ab Prognostic method for individuals with prostate cancer
KR101944927B1 (ko) 2016-03-24 2019-02-07 서울대학교산학협력단 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발
WO2017164699A1 (ko) * 2016-03-24 2017-09-28 서울대학교병원 (분사무소) 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발
KR102068667B1 (ko) * 2019-02-28 2020-01-21 주식회사 프로카젠 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체
KR102371654B1 (ko) * 2019-02-28 2022-03-08 주식회사 프로카젠 유전 변이의 개수에 따른 예측력을 고려한 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체
KR102068666B1 (ko) * 2019-02-28 2020-02-11 주식회사 프로카젠 인종 별 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체
KR102371655B1 (ko) * 2019-02-28 2022-03-08 주식회사 프로카젠 각 유전 변이 정보에 개별적인 가중치를 부여한 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체
CN110596060B (zh) * 2019-09-12 2020-08-21 江南大学 一种检测前列腺特异性抗原的光谱分析中荧光传感器的构建方法及其应用

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
DE131052T1 (de) 1983-01-10 1987-03-19 Gen-Probe Partners, San Diego, Calif. Verfahren zum aufspueren, identifizieren und quantifizieren von organismen und viren.
US5288611A (en) 1983-01-10 1994-02-22 Gen-Probe Incorporated Method for detecting, identifying, and quantitating organisms and viruses
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US6054270A (en) 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
EP1541682A3 (en) 1988-09-02 2005-07-06 Dyax Corp. Generation and selection of recombinant varied binding proteins
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5288644A (en) 1990-04-04 1994-02-22 The Rockefeller University Instrument and method for the sequencing of genome
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
JPH06508511A (ja) 1990-07-10 1994-09-29 ケンブリッジ アンティボディー テクノロジー リミティド 特異的な結合ペアーの構成員の製造方法
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DE69129154T2 (de) 1990-12-03 1998-08-20 Genentech, Inc., South San Francisco, Calif. Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
ES2155822T3 (es) 1990-12-06 2001-06-01 Affymetrix Inc Compuestos y su utilizacion en una estrategia de sintesis binaria.
DE69233769D1 (de) 1991-03-01 2009-09-24 Dyax Corp Chimäres Protein mit Mikroprotein mit zwei oder mehr Disulfidbindungen und Ausgestaltungen davon
ATE414768T1 (de) 1991-04-10 2008-12-15 Scripps Research Inst Bibliotheken heterodimerer rezeptoren mittels phagemiden
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
US5384261A (en) 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US6287850B1 (en) 1995-06-07 2001-09-11 Affymetrix, Inc. Bioarray chip reaction apparatus and its manufacture
DE69527585T2 (de) 1994-06-08 2003-04-03 Affymetrix, Inc. Verfahren und Vorrichtung zum Verpacken von Chips
US6300063B1 (en) 1995-11-29 2001-10-09 Affymetrix, Inc. Polymorphism detection
JP4468488B2 (ja) 1996-05-29 2010-05-26 コーネル・リサーチ・ファンデーション・インコーポレイテッド 組み合せたリガーゼ検出およびポリメラーゼ連鎖反応を用いる核酸配列相違の検出
US5925519A (en) * 1996-06-03 1999-07-20 The Regents Of The University Of California Genetic alterations associated with prostate cancer
AU773006B2 (en) 1998-06-05 2004-05-13 Genset S.A. Polymorphic markers of prostate carcinoma tumor antigen-1 (PCTA-1)
US6355623B2 (en) * 1998-09-24 2002-03-12 Hopital-Sainte-Justine Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage
AU1467900A (en) * 1998-11-06 2000-05-29 Hospital For Sick Children, The Chromosome 17p-linked prostate cancer susceptibility gene
US6429027B1 (en) 1998-12-28 2002-08-06 Illumina, Inc. Composite arrays utilizing microspheres
AU2003276973A1 (en) 2002-09-25 2004-04-19 Amersham Biosciences (Sv) Corp. Detection methods
US20050136407A1 (en) 2003-12-19 2005-06-23 Cramer Scott D. Genetic polymorphisms in the prostate-specific antigen gene promoter
US20050255507A1 (en) 2004-02-17 2005-11-17 Jenkins Robert B Cytogenetically determined diagnosis and prognosis of proliferative disorders
WO2006063285A2 (en) 2004-12-10 2006-06-15 Sequenom, Inc. Methods for identifying risk of breast cancer or prostate cancer and treatments thereof
WO2006123369A1 (en) * 2005-05-18 2006-11-23 Decode Genetics Ehf. Variants at chr8q24.21 confer risk of cancer
WO2008050356A1 (en) * 2006-10-27 2008-05-02 Decode Genetics Cancer susceptibility variants on chr8q24.21
US8697360B2 (en) * 2007-11-30 2014-04-15 Decode Genetics Ehf. Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition

Similar Documents

Publication Publication Date Title
JP2010520745A5 (enExample)
JP2010507388A5 (enExample)
JP2011530306A5 (enExample)
EP2253713B1 (en) Method for measuring chromosome, gene or specific nucleotide sequence copy numbers using snp array
JP2010527603A5 (enExample)
JP2014533949A5 (enExample)
JP2010533477A5 (enExample)
JP2010518848A5 (enExample)
JP2012525147A5 (enExample)
BR112012023698B1 (pt) Ensaios multiplex, método e kit para identificar e diferenciar mrsa, mssa, mrse, msse, msse, mrcns ou mscns
TWI889083B (zh) 可實施2種以上檢測的遺傳學分析方法
HK1254361A1 (zh) Snp rs12603226作为nafld的预测性标记物
JP2010510804A5 (enExample)
EP3315613B1 (en) Methods and kits for diagnosing or assessing the risk of cervical cancer
CN104131101B (zh) 一种检测p53基因snp位点的试剂及其应用
CN105483279A (zh) 基于AllGlo探针的rs3909184检测分型试剂盒及其分型方法
KR102268059B1 (ko) 운동 민감도 예측용 조성물, 키트, 및 이를 이용한 방법
KR20210066620A (ko) 우리흑돈의 전신 흑모색 식별용 snp 마커 및 이를 이용한 전신 흑모색 식별 방법
KR102816628B1 (ko) 대사증후군 특이적 후성유전 메틸화 마커 및 이의 용도
JP2012000081A (ja) Snpによる肥満化のリスクの予測
RU2617936C2 (ru) Способ экспресс-анализа генетического полиморфизма для выявления генетической предрасположенности к раку молочной железы
KR20250089586A (ko) ctDNA 단일염기변이를 이용한 반려견의 종양 진단 방법
KR20250089585A (ko) ctDNA 단일염기변이를 이용한 반려견의 종양 진단용 조성물
RU2445373C1 (ru) СПОСОБ ОПРЕДЕЛЕНИЯ ГЕНОТИПА ЧЕЛОВЕКА ПО ПОЛИМОРФИЗМУ В ПОЗИЦИИ 4343 ГЕНА BRCA1 (rs1799950)
CN120967014A (zh) 快速检测藏鸡经济性状的pls3基因snp标记及检测方法和应用